Trial Profile
Alendronic acid vs raloxifene in postmenopausal osteoporotic women with primary hyperthyroidism
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Mar 2014
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary) ; Raloxifene (Primary)
- Indications Postmenopausal osteoporosis; Primary hyperparathyroidism
- Focus Therapeutic Use
- 29 Mar 2014 New trial record